{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T13:01:56Z","timestamp":1789650116462,"version":"4.0.0"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:00:00Z","timestamp":1789603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Diabetic kidney disease (DKD) has become the main cause of end-stage renal disease in China. Mounting evidence links microecological disorders to DKD progression. However, the composition and the functional characteristics of the renal microecology in DKD patients remain poorly defined. This study characterized renal tissue microbiota and metabolite profiles in DKD patients, aiming to provide insights for novel diagnostic strategies for DKD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Renal tissue microbiome was analyzed in 42 DKD patients and 10 controls via 16S ribosomal DNA sequencing. Renal metabolomics was performed in 20 DKD patients and 10 controls using liquid chromatography-tandem mass spectrometry (LC-MS\/MS). Spearman correlation analysis clarified associations of clinical parameters with renal microbiome and metabolites. Biomarkers were identified by multi-omics integration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      IHC, IF and TEM reveals the presence of bacteria in both glomeruli and renal tubules. A significant separation in microbial community composition was observed between DKD patients and controls (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.05). The relative abundance of\n                      <jats:italic>Acidobacteriota<\/jats:italic>\n                      ,\n                      <jats:italic>Acinetobacter<\/jats:italic>\n                      and\n                      <jats:italic>Afipia<\/jats:italic>\n                      genus were significantly elevated in DKD group, whereas\n                      <jats:italic>Ralstonia<\/jats:italic>\n                      genus was decreased. Notably, the genus\n                      <jats:italic>Acinetobacter<\/jats:italic>\n                      demonstrated a significant negative correlation with the eGFR, while\n                      <jats:italic>Afipia<\/jats:italic>\n                      genus exhibited a significant positive correlation with blood glucose levels. Renal microbiota resembled urinary microbiota more closely than gut microbiota. Metabolomic analysis revealed significant difference in renal tissue metabolites between DKD patients and healthy controls. Lactate, hypoxanthine and phosphorylcholine were significantly positively correlated with the eGFR. Comprehensive multivariate analyses identified the genus\n                      <jats:italic>Ralstonia<\/jats:italic>\n                      as a crucial biomarker associated with renal fibrotic injury in DKD, consistent across urinary and gut microbiomes. Decreased serum levels of stearylcarnitine (Car18:0), oleylcarnitine (Car18:1) and tryptophan were closely associated with renal injury, whereas decreased urinary serine and tyramine levels reflected the change of renal metabolites in DKD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our finding confirms the existence of microbiota within renal tissue and demonstrates that its structure and composition are significantly altered in DKD. These disruptions in renal microecology are closely associated with the progression of DKD. Multi-omics analysis further identified a panel of candidate markers for evaluation of DKDs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmicb.2026.1898177","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:03:20Z","timestamp":1789646600000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Renal tissue microbiota and metabolite profiling reveal dysregulated signatures in diabetic kidney disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Na","family":"Zhao","sequence":"first","affiliation":[{"name":"The Basic Medical College of Shanxi Medical University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijia","family":"Leng","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College of Shanxi Medical University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiqi","family":"Li","sequence":"additional","affiliation":[{"name":"The Basic Medical College of Shanxi Medical University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Wei","sequence":"additional","affiliation":[{"name":"The Basic Medical College of Shanxi Medical University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College of Shanxi Medical University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Key Laboratory of Cellular Physiology, Ministry of Education, Department of Physiology, Shanxi Medical University","place":["Taiyuan, China"]},{"name":"Shanxi Provincial Key Laboratory of Aging-related Diseases Mechanisms and Translation","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College of Shanxi Medical University, Taiyuan","place":["Shanxi, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10509","DOI":"10.1038\/s41467-024-54432-6","article-title":"Cefazolin shifts the kidney microbiota to promote a lithogenic environment.","volume":"15","author":"Agudelo","year":"2024","journal-title":"Nat. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine.","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"key":"B3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s40168-021-01039-4","article-title":"An atlas of the tissue and blood metagenome in cancer reveals novel links between bacteria, viruses and cancer.","volume":"9","author":"Borchmann","year":"2021","journal-title":"Microbiome"},{"key":"B4","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/s41577-023-00874-w","article-title":"Early-life interactions between the microbiota and immune system: Impact on immune system development and atopic disease.","volume":"23","author":"Donald","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41579-020-0433-9","article-title":"Gut microbiota in human metabolic health and disease.","volume":"19","author":"Fan","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"7454","DOI":"10.1111\/dom.70153","article-title":"Integrative metabolomic and proteomic analysis of diabetic kidney disease progression with younger-onset type 2 diabetes.","volume":"27","author":"Gurung","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"B7","doi-asserted-by":"publisher","first-page":"30751","DOI":"10.1038\/srep30751","article-title":"The microbiome of aseptically collected human breast tissue in benign and malignant disease.","volume":"6","author":"Hieken","year":"2016","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"12179","DOI":"10.1038\/s41598-025-91281-9","article-title":"Predicting diabetic kidney disease with serum metabolomics and gut microbiota.","volume":"15","author":"Hu","year":"2025","journal-title":"Sci. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"101463","DOI":"10.1016\/j.lanwpc.2024.101463","article-title":"Prevalence of chronic kidney disease among Chinese adults with diabetes: A nationwide population-based cross-sectional study.","volume":"55","author":"Jia","year":"2025","journal-title":"Lancet Reg. Health West Pac."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.7150\/thno.80435","article-title":"Integration of metabolomics and peptidomics reveals distinct molecular landscape of human diabetic kidney disease.","volume":"13","author":"Jiang","year":"2023","journal-title":"Theranostics"},{"key":"B11","doi-asserted-by":"publisher","first-page":"123209","DOI":"10.1016\/j.carbpol.2024.123209","article-title":"Correlation between the structures of natural polysaccharides and their properties in regulating gut microbiota: Current understanding and beyond.","volume":"352","author":"Keung","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"B12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1186\/s12967-025-06405-6","article-title":"Urobiome of patients with diabetic kidney disease in different stages is revealed by 2bRAD-M.","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","article-title":"Lung microbiome: New insights into the pathogenesis of respiratory diseases.","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12879-023-08506-3","article-title":"A case of meningitis caused by Ralstonia insidiosa, a rare opportunistic pathogen.","volume":"23","author":"Liao","year":"2023","journal-title":"BMC Infect. Dis."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1681\/ASN.2021060843","article-title":"Intestinal bacterial translocation contributes to diabetic kidney disease.","volume":"33","author":"Linh","year":"2022","journal-title":"J. Am. Soc. Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2143220","DOI":"10.1080\/19490976.2022.2143220","article-title":"Kidney microbiota dysbiosis contributes to the development of hypertension.","volume":"14","author":"Liu","year":"2022","journal-title":"Gut. Microbes."},{"key":"B17","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/01.asn.0000093239.32602.04","article-title":"Renal replacement therapy in patients with diabetes and end-stage renal disease.","volume":"15","author":"Locatelli","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2552913","DOI":"10.1080\/0886022X.2025.2552913","article-title":"Triptolide improves microbial dysbiosis and metabolite disorder in db\/db mice.","volume":"47","author":"Lu","year":"2025","journal-title":"Ren. Fail."},{"key":"B19","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12890-023-02316-8","article-title":"Spherical pneumonia caused by Ralstonia mannitolilytica: A case report and literature review.","volume":"23","author":"Ma","year":"2023","journal-title":"BMC Pulm. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1136\/gutjnl-2019-320118","article-title":"Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes.","volume":"69","author":"Massier","year":"2020","journal-title":"Gut"},{"key":"B21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria.","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"B22","doi-asserted-by":"publisher","first-page":"108166","DOI":"10.1016\/j.biotechadv.2023.108166","article-title":"Complex alpha and beta mannan foraging by the human gut bacteria.","volume":"66","author":"Panwar","year":"2023","journal-title":"Biotechnol. Adv."},{"key":"B23","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1021\/acs.jproteome.5c00188","article-title":"Whole blood metabolome profiling for stratification of type 2 diabetes patients and identification of biomarkers for diabetic kidney disease in Asian Indian adults.","volume":"24","author":"Rana","year":"2025","journal-title":"J. Proteome. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI).","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7355","DOI":"10.1111\/dom.70138","article-title":"Unveiling urinary diagnostic biomarkers for diabetic kidney disease using metabolomics and machine learning approaches.","volume":"27","author":"Sun","year":"2025","journal-title":"Diabetes Obes. Metab."},{"key":"B26","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy.","volume":"21","author":"Tervaert","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4505","DOI":"10.1038\/s41467-019-12476-z","article-title":"Interplay between the human gut microbiome and host metabolism.","volume":"10","author":"Visconti","year":"2019","journal-title":"Nat. Commun."},{"key":"B28","doi-asserted-by":"publisher","first-page":"581.e","DOI":"10.1016\/j.cmet.2022.02.010","article-title":"The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer.","volume":"34","author":"Wang","year":"2022","journal-title":"Cell. Metab."},{"key":"B29","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrurol.2014.361","article-title":"The microbiome of the urinary tract\u2013a role beyond infection.","volume":"12","author":"Whiteside","year":"2015","journal-title":"Nat. Rev. Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1606700","DOI":"10.3389\/fcimb.2025.1606700","article-title":"The alternations of gut microbiota in diabetic kidney disease: Insights from a triple comparative cohort.","volume":"15","author":"Wu","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1089","DOI":"10.1016\/S2468-2667(24)00250-0","article-title":"Diabetes in China part 1: Epidemiology and risk factors.","volume":"9","author":"Xu","year":"2024","journal-title":"Lancet Public Health"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e17040","DOI":"10.1016\/j.heliyon.2023.e17040","article-title":"Urinary microbiota and serum metabolite analysis in patients with diabetic kidney disease.","volume":"9","author":"Yang","year":"2023","journal-title":"Heliyon"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1126\/science.aao5774","article-title":"Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes.","volume":"359","author":"Zhao","year":"2018","journal-title":"Science"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1898177\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:03:21Z","timestamp":1789646601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2026.1898177\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":33,"alternative-id":["10.3389\/fmicb.2026.1898177"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2026.1898177","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,17]]},"article-number":"1898177"}}